Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Membrane Biology|June 24, 2004
Binding and release of cytochrome c in brain mitochondria is influenced by membrane potential and hydrophobic interactions with cardiolipinL Piccotti, M Buratta, S Giannini, et al.
The Journal of Clinical Investigation|November 1, 1987
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonismP Gresele, J Arnout, H Deckmyn, et al.
Lancet (London, England)|May 5, 1984
BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in manP Gresele, H Deckmyn, J Arnout, et al.
Thrombosis and Haemostasis|December 30, 1983
Dipyridamole inhibits platelet aggregation in whole bloodP Gresele, C Zoja, H Deckmyn, et al.
Minerva Stomatologica|March 1, 1996
[The measurement of PAF (platelet activating factor) in human saliva: standardization of the method]N Staffolani, M Gefrra, E Ribaldi, et al.
Gynecologic and Obstetric Investigation|January 1, 1991
Red cell deformability alterations in normal late pregnancy: possible role of plasma componentsP Tamàs, P Gresele, A Kett, et al.
Thrombosis and Haemostasis|May 9, 2001
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PAM Colucci, A M D'Aprile, A Italia, et al.
Lipids|March 1, 1983
Cholinephosphotransferase activity in human plateletsG Goracci, P Gresele, G Arienti, et al.
Cell Biochemistry and Function|March 1, 1995
Platelet glycohydrolase activities: characterization and releaseC Emiliani, S Martino, A Orlacchio, et al.
European Journal of Clinical Pharmacology|January 1, 1987
In vitro and ex vivo effects of indobufen on red blood cell deformabilityS Grasselli, R Guerciolini, V Iadevaia, et al.
Pageof 11